(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
The omicron variant of COVID-19 has caused a surge in symptoms and positive cases across the United States, and since a few of the symptoms resemble a common cold, one question some are asking is: Did ...
Laboratory Corporation of America Holdings or LabCorp LH recently gained FDA emergency use authorization (EUA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II ...
June 25 (Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results